Swiss Life Asset Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $167M | Sell |
6,943,719
-389,228
| -5% | -$10.2M | 0.69% | 26 |
|
|
2026
Q1 | $206M | Buy |
7,332,947
+491,766
| +7% | +$13.1M | 1.01% | 14 |
|
|
2025
Q4 | $170M | Buy |
6,841,181
+1,138,482
| +20% | +$28.7M | 0.87% | 15 |
|
|
2025
Q3 | $145M | Sell |
5,702,699
-126,498
| -2% | -$3.12M | 0.76% | 21 |
|
|
2025
Q2 | $141M | Buy |
5,829,197
+143,529
| +3% | +$3.35M | 0.83% | 19 |
|
|
2025
Q1 | $144M | Buy |
5,685,668
+124,033
| +2% | +$3.25M | 1.05% | 18 |
|
|
2024
Q4 | $148M | Buy |
5,561,635
+4,246,633
| +323% | +$115M | 1.09% | 15 |
|
|
2024
Q3 | $38M | Sell |
1,315,002
-76,141
| -5% | -$2.22M | 0.43% | 49 |
|
|
2024
Q2 | $38.9M | Buy |
1,391,143
+210,367
| +18% | +$5.79M | 0.46% | 45 |
|
|
2024
Q1 | $32.8M | Buy |
1,180,776
+1,280
| +0.1% | +$35.5K | 0.46% | 51 |
|
|
2023
Q4 | $34M | Buy |
1,179,496
+172,666
| +17% | +$5.22M | 0.41% | 43 |
|
|
2023
Q3 | $33.4M | Sell |
1,006,830
-15,852
| -2% | -$561K | 0.52% | 33 |
|
|
2023
Q2 | $37.5M | Sell |
1,022,682
-29,046
| -3% | -$1.13M | 0.56% | 30 |
|
|
2023
Q1 | $42.9M | Sell |
1,051,728
-47,412
| -4% | -$2.05M | 0.65% | 24 |
|
|
2022
Q4 | $56.4M | Buy |
1,099,140
+8,335
| +0.8% | +$400K | 0.94% | 13 |
|
|
2022
Q3 | $47.7M | Buy |
1,090,805
+279,096
| +34% | +$13.6M | 0.82% | 16 |
|
|
2022
Q2 | $42.6M | Sell |
811,709
-165,360
| -17% | -$8.43M | 0.69% | 23 |
|
|
2022
Q1 | $50.5M | Sell |
977,069
-75,095
| -7% | -$3.9M | 0.71% | 20 |
|
|
2021
Q4 | $62.1M | Buy |
1,052,164
+23,587
| +2% | +$1.17M | 0.81% | 13 |
|
|
2021
Q3 | $44.2M | Sell |
1,028,577
-96,575
| -9% | -$4.28M | 0.61% | 28 |
|
|
2021
Q2 | $41.6M | Buy |
1,125,152
+95,806
| +9% | +$3.73M | 0.42% | 33 |
|
|
2021
Q1 | $37.3M | Sell |
1,029,346
-41,410
| -4% | -$1.47M | 0.53% | 31 |
|
|
2020
Q4 | $39.4M | Buy |
1,070,756
+3,067
| +0.3% | +$112K | 0.58% | 28 |
|
|
2020
Q3 | $37.2M | Sell |
1,067,689
-308,916
| -22% | -$10.8M | 0.55% | 37 |
|
|
2020
Q2 | $42.7M | Buy |
1,376,605
+80,974
| +6% | +$2.75M | 0.69% | 30 |
|
|
2020
Q1 | $40.1M | Sell |
1,295,631
-149,017
| -10% | -$5.08M | 0.76% | 26 |
|
|
2019
Q4 | $53.7M | Sell |
1,444,648
-716,015
| -33% | -$25.5M | 1.02% | 19 |
|
|
2019
Q3 | $73.7M | Sell |
2,160,663
-46,050
| -2% | -$1.67M | 0.96% | 22 |
|
|
2019
Q2 | $90.7M | Buy |
2,206,713
+12,959
| +0.6% | +$515K | 1.1% | 18 |
|
|
2019
Q1 | $88.4M | Buy |
2,193,754
+364,563
| +20% | +$14.6M | 1.12% | 17 |
|
|
2018
Q4 | $75.8M | Sell |
1,829,191
-554,416
| -23% | -$23M | 1.54% | 14 |
|
|
2018
Q3 | $99.7M | Buy |
2,383,607
+80,838
| +4% | +$3.11M | 1.34% | 12 |
|
|
2018
Q2 | $79.3M | Buy |
2,302,769
+323,859
| +16% | +$11.1M | 1.19% | 16 |
|
|
2018
Q1 | $66.6M | Sell |
1,978,910
-57,627
| -3% | -$1.98M | 1.17% | 14 |
|
|
2017
Q4 | $70M | Buy |
2,036,537
+525,043
| +35% | +$17.9M | 1.56% | 8 |
|
|
2017
Q3 | $51.2M | Buy |
1,511,494
+78,425
| +5% | +$2.52M | 1.37% | 9 |
|
|
2017
Q2 | $45.7M | Sell |
1,433,069
-68,982
| -5% | -$2.18M | 1.18% | 10 |
|
|
2017
Q1 | $48.8M | Buy |
1,502,051
+330,512
| +28% | +$10.4M | 1.31% | 10 |
|
|
2016
Q4 | $36.1M | Buy |
1,171,539
+358,263
| +44% | +$10.9M | 1.21% | 12 |
|
|
2016
Q3 | $26.1M | Buy |
813,276
+57,416
| +8% | +$1.92M | 0.89% | 13 |
|
|
2016
Q2 | $25.2M | Buy |
755,860
+38,418
| +5% | +$1.23M | 1.04% | 11 |
|
|
2016
Q1 | $20.2M | Sell |
717,442
-15,622
| -2% | -$446K | 0.85% | 21 |
|
|
2015
Q4 | $22.5M | Buy |
733,064
+38,209
| +5% | +$1.2M | 1% | 13 |
|
|
2015
Q3 | $20.7M | Buy |
694,855
+10,839
| +2% | +$348K | 1.01% | 14 |
|
|
2015
Q2 | $21.8M | Sell |
684,016
-36,902
| -5% | -$1.2M | 0.76% | 14 |
|
|
2015
Q1 | $23.8M | Buy |
+720,918
| New | +$22.9M | 0.96% | 12 |
|
Other funds holding PFE
Swiss Life Asset Management's PFE Position: Q2 2026 in Review
Swiss Life Asset Management reduced its Pfizer (PFE) stake by 5.3% in Q2 2026, selling an estimated $10.2M and leaving 6,943,719 shares worth $167M. The position accounts for 0.69% of the portfolio, ranked #26.
Swiss Life Asset Management first reported a position in PFE in Q1 2015 and has held it in 46 quarters since. The position peaked at $206M in Q1 2026. 2,142 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Swiss Life Asset Management held 6,943,719 shares of Pfizer worth $167M as of Q2 2026.
- Swiss Life Asset Management sold 389,228 Pfizer shares in Q2 2026, an estimated $10.2M.
- Pfizer made up 0.69% of Swiss Life Asset Management's portfolio in Q2 2026, its #26 holding.
- Swiss Life Asset Management first reported a position in Pfizer in Q1 2015 and has held it in 46 quarters since.
- Swiss Life Asset Management's Pfizer position peaked at $206M in Q1 2026.
- 2,142 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Swiss Life Asset Management's 13F filing for Q2 2026, filed 29 Jul 2026.